Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories


	PCI / Devices: 130 submissions (showing 46 to 60)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 |

Dr. Felix Zijlstra presents the TAPAS Study
, Dr. Felix Zijlstra

Meta-analysis of DES vs BMS
, Dr. C. Michael Gibson, Dr. Ajay Kirtane

Interventional Management of the High-risk Patient
Dr. Ted Feldman

Dr. Roxana Mehran Presents: In-Stent Restenosis and Late Stent Thrombosis
Dr. Roxana Mehran

Findings and Controversies Arising from the COURAGE Trial: Implications for Interventional Cardiologists
Dr. C. Michael Gibson, Dr. Jeffrey Popma, MD, Dr. Dean J. Kereiakes, MD

Dr. Ted Bass and Dr. Michael Nguyen discuss the future of device therapies and how to best train fellows to use infreque
Dr. Michael Nguyen, Dr. Ted Bass

Understanding Chronic CAD: Obstructive Stable Lesions Vs. Non-Obstructive Vulnerable Plaque
Dr. Peter Stone

In-Vivo Identification of High-Risk Coronary Plaque from Endothelial Shear Stress and Expansive Vascular Remodeling
Dr. Peter Stone

Dr. Kotani, Dr. Nanto, and Dr. Awata provide their insights on the use of angioscopy
Dr. Shinsuke Nanto, Dr. Masaki Awata, Dr. Jun-ichi Katani, Dr. C. Michael Gibson

Dr. Steve Wiviott and Dr. Paul Gurbel Discuss Antiplatelet Resistance
Dr. Paul Gurbel, Dr. Stephen Wiviott

TAXUS ATLAS Small Vessel and Long Lesion Study by Dr. Mark Turco
Dr. Mark Turco

SPIRIT III: Trial designed to compare Abbott’s XIENCE V Everolimus Eluting Coronary Stent System with Boston Scientifi
Dr. Gregg Stone

Drs. Fadel and Hennebry: The Landmark vs Fluoroscopy in Obtaining Arterial Access. A Look at Randomized Data
Dr. Mazen Fadel, Dr. Thomas Hennebry

Targeting Hemoglobin and the Use of Erythropoietin and Transfusion in Cardiac Patients
Dr. Peter McCullough

James G. Jollis, MD and Mayme L. Roettig RN, MSN discuss the results of the RACE Trial
Dr. James Jollis, Ms. Mayme Roettig